Insider · CIK 0001619259

SCHECHTER JONATHAN

Reports to the SEC for 6 companies · LAS VEGAS, NV

sec.gov

Transactions

Companies

Filings

CIK

0001619259

Forms 4 and 5

Insider transactions

41 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-31	PMCBPharmaCyte Biotech, Inc. · Stock Option (Right to Buy)J Other	Director	JOther	0 sh	—	—	0
2026-03-31	PMCBPharmaCyte Biotech, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+119K sh	—	—	119,170
2026-01-07	PMCBPharmaCyte Biotech, Inc.P Purchase	Director	PPurchase	+20K sh	$0.84	+$16.9K	192,500
2026-01-06	PMCBPharmaCyte Biotech, Inc.P Purchase	Director	PPurchase	+20K sh	$0.79	+$15.8K	172,500
2026-01-05	PMCBPharmaCyte Biotech, Inc.P Purchase	Director	PPurchase	+20K sh	$0.78	+$15.6K	152,500
2025-12-12	PMCBPharmaCyte Biotech, Inc.F Tax Payment	Director	FTax Payment	−67.5K sh	$1.02	−$68.9K	132,500
2025-12-12	PMCBPharmaCyte Biotech, Inc.A Award	Director	AAward	+150K sh	—	—	200,000
2025-11-14	TWAVTaoWeave, Inc.P Purchase	Director	PPurchase	+10K sh	$1.91	+$19.1K	25,000
2025-09-17	TWAVTaoWeave, Inc.P Purchase	Director	PPurchase	+5,000 sh	$2.70	+$13.5K	15,000
2025-09-16	TWAVTaoWeave, Inc.P Purchase	Director	PPurchase	+10K sh	$2.73	+$27.3K	10,000
2025-08-06	TAOXTAO Synergies Inc. · Employee Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2025-06-30	TAOXTAO Synergies Inc.F Tax Payment	Director	FTax Payment	−8,630 sh	$7.85	−$67.7K	14,035
2025-06-30	TAOXTAO Synergies Inc.A Award	Director	AAward	+21.6K sh	—	—	22,665
2025-04-25	PMCBPharmaCyte Biotech, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+63.2K sh	—	—	63,233
2025-04-03	TAOXTAO Synergies Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+800 sh	—	—	800
2024-04-30	PMCBPharmaCyte Biotech, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+38K sh	—	—	38,009
2024-04-08	TAOXTAO Synergies Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+800 sh	—	—	800
2023-11-20	PMCBPharmaCyte Biotech, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+61.2K sh	—	—	61,248
2023-03-29	TAOXTAO Synergies Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2022-12-16	TAOXTAO Synergies Inc.S Sale	Director	SSale	−20.3K sh	$1.17	−$23.7K	28,500
2022-11-15	TAOXTAO Synergies Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+72K sh	—	—	72,000
2022-04-05	TAOXTAO Synergies Inc. · Stock Option (Right to Buy)J Other	Director	JOther	0 sh	—	—	0
2022-04-05	TAOXTAO Synergies Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,500 sh	—	—	1,500
2021-07-13	TAOXTAO Synergies Inc.A Award	Director	AAward	+45K sh	—	—	48,750
2020-12-01	Neurotrope, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,562 sh	—	—	0
2020-12-01	Neurotrope, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−50K sh	—	—	0
2020-12-01	Neurotrope, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,813 sh	—	—	0
2020-12-01	Neurotrope, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2020-12-01	Neurotrope, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2020-12-01	Neurotrope, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2020-12-01	Neurotrope, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−80K sh	—	—	0
2020-11-24	Neurotrope, Inc.Stock Option (right to buy)A Award	Director	AAward	+80K sh	—	—	80,000
2020-10-30	Neurotrope, Inc.P Purchase	Director	PPurchase	+25K sh	$0.98	+$24.4K	75,000
2020-10-22	Neurotrope, Inc.P Purchase	Director	PPurchase	+25K sh	$1.10	+$27.5K	50,000
2020-10-21	Neurotrope, Inc.P Purchase	Director	PPurchase	+23K sh	$1.10	+$25.3K	25,000
2020-10-20	Neurotrope, Inc.P Purchase	Director	PPurchase	+2,012 sh	$1.10	+$2,213.2	2,012
2020-03-20	Neurotrope, Inc.Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2019-03-15	Neurotrope, Inc.Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2019-01-22	Neurotrope, Inc.Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2018-12-13	Neurotrope, Inc.Stock Option (right to buy)A Award	Director	AAward	+1,562 sh	—	—	1,562
2018-12-13	Neurotrope, Inc.Stock Option (right to buy)A Award	Director	AAward	+7,813 sh	—	—	7,813

Recent filings

Accepted (ET)
Jul 174/A
SCHECHTER JONATHAN0001683168-26-005620
SEC(opens sec.gov)
Apr 24
SCHECHTER JONATHAN0001683168-26-002631
SEC(opens sec.gov)
Jan 74
SCHECHTER JONATHAN0001683168-26-000147
SEC(opens sec.gov)
Dec 124
SCHECHTER JONATHAN0001683168-25-009113
SEC(opens sec.gov)
Nov 174
SCHECHTER JONATHAN0001437749-25-035345
SEC(opens sec.gov)
Oct 174
SCHECHTER JONATHAN0001104659-25-100460
SEC(opens sec.gov)
Sep 174
SCHECHTER JONATHAN0001437749-25-029280
SEC(opens sec.gov)
Sep 164
SCHECHTER JONATHAN0001437749-25-029161
SEC(opens sec.gov)
Jul 24
SCHECHTER JONATHAN0001104659-25-065278
SEC(opens sec.gov)
Apr 74
SCHECHTER JONATHAN0001104659-25-032682
SEC(opens sec.gov)
Jul 174
SCHECHTER JONATHAN0001683168-24-004916
SEC(opens sec.gov)
Apr 104
SCHECHTER JONATHAN0001104659-24-045799
SEC(opens sec.gov)
Nov 224
SCHECHTER JONATHAN0001683168-23-008430
SEC(opens sec.gov)
Mar 314
SCHECHTER JONATHAN0001104659-23-040203
SEC(opens sec.gov)
Dec 204
SCHECHTER JONATHAN0001104659-22-128769
SEC(opens sec.gov)

Companies

Address

C/O PHARMACYTE BIOTECH, INC. 3960 HOWARD HUGHES PARKWAY, SUITE 500

LAS VEGAS, NV, 89169